|
|
|
Volumn 18, Issue 101, 2009, Pages 97-99
|
|
Dabigatran: Continue to use heparin, a better-known option
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
AMIODARONE;
ANTIVITAMIN K;
DABIGATRAN;
DABIGATRAN ETEXILATE;
DANAPAROID;
DESULFATOHIRUDIN;
ENOXAPARIN;
FONDAPARINUX;
HEPARIN;
HIRUDIN;
LEPIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
MELAGATRAN;
QUINIDINE;
RIVAROXABAN;
XIMELAGATRAN;
ANTICOAGULANT AGENT;
BENZIMIDAZOLE DERIVATIVE;
BLOOD CLOTTING FACTOR 10A;
FIBRINOLYTIC AGENT;
PRODRUG;
PYRIDINE DERIVATIVE;
THROMBIN;
VITAMIN K GROUP;
ACUTE HEART FAILURE;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ANTICOAGULATION;
BLEEDING;
BLOOD TRANSFUSION;
CLINICAL TRIAL;
CREATININE CLEARANCE;
DEEP VEIN THROMBOSIS;
DRUG EFFICACY;
DRUG POTENCY;
DRUG WITHDRAWAL;
HEART DEATH;
HEART DISEASE;
HEART INFARCTION;
HEPARIN INDUCED THROMBOCYTOPENIA;
HIP ARTHROPLASTY;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
KIDNEY FAILURE;
KNEE ARTHROPLASTY;
LIVER DISEASE;
LIVER TOXICITY;
LUNG EMBOLISM;
PATIENT MONITORING;
RISK FACTOR;
SHORT SURVEY;
SIDE EFFECT;
THROMBOCYTE COUNT;
TREATMENT INDICATION;
UNSTABLE ANGINA PECTORIS;
WOUND DEHISCENCE;
ANTICOAGULANT THERAPY;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
DRUG APPROVAL;
FRANCE;
RANDOMIZED CONTROLLED TRIAL;
THROMBOEMBOLISM;
VEIN THROMBOSIS;
ANTICOAGULANTS;
ARTHROPLASTY, REPLACEMENT, HIP;
ARTHROPLASTY, REPLACEMENT, KNEE;
BENZIMIDAZOLES;
DRUG APPROVAL;
ENOXAPARIN;
FACTOR XA;
FIBRINOLYTIC AGENTS;
FRANCE;
HEMORRHAGE;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HIRUDIN THERAPY;
HUMANS;
PRODRUGS;
PYRIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
THROMBIN;
THROMBOEMBOLISM;
VENOUS THROMBOSIS;
VITAMIN K;
|
|
EID: 66849121888
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (6)
|
|
References (10)
|
